[Endocrinology and therapy of breast diseases]

M. Breckwoldt
Zentralblatt für Gynäkologie · 1990 · vol. 112(17) , pp. 1097–9 · PMID:2264419 · W2408363145
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-04 ⓘ

The provided text does not contain information regarding endometriosis or adenomyosis, so it cannot be summarized according to the specified corpus constraints.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In 193 patients with fibrocystic breast diseases in 46% basal prolactin levels were elevated and many women had an increased reaction to TRH test with increased TSH and PRL serum levels. The author recommend for treatment progestogens dopamine antagonists and danazol.

My notes (saved in your browser only)

MeSH descriptors

Estradiol Fibrocystic Breast Disease Progesterone Prolactin Animals Breast Breast Estradiol Female Fibrocystic Breast Disease Humans Progesterone Prolactin

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

SciLite annotations

chemicals 2
dopamine danazol

Source provenance

openalex
last seen: 2026-05-10T10:34:35.259320+00:00
pubmed
last seen: 2026-10-08T21:10:28.861444+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK